Oleg Nodelman’s EcoR1 Capital Betting On Transcept Pharmaceuticals Inc (TSPT)

Oleg Nodelman’s EcoR1 Capital disclosed a new $2.3 Transcept Pharmaceuticals Inc (NASDAQ:TSPT) on Friday. EcoR1 Capital reported a 5.5% passive stake in this specialty pharmaceutical company. Oleg Nodelman cut his teeth at Mark Lampert’s BVF Inc working as an analyst and portfolio manager for more than a decade. Jim Roumell has a huge position in Transcept Pharmaceuticals Inc (NASDAQ:TSPT). Mark Lampert also initiated a brand new $300 thousand position in the stock during the first quarter.

At the end of 2013 Oleg Nodelman disclosed a large position in Kindred Biosciences Inc (NASDAQ:KIN). The stock performed well in the first few months of this year. However, it gave back its returns later in the year and is now down more than 5% for the year.

 

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!